In HER-2 negative cancer (n = 291, table 5), positive CD8+ CTLs infiltrate status had significant associations with improved DFS (Log-rank test: P = 0.005, Fig. 4A) and OS (Log-rank test: P = 0.049, Fig. 4B). Here, ERBB2 is linked to cancer.